Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytosorbents

1.09
+0.02001.87%
Post-market: 1.090.00000.00%16:00 EDT
Volume:69.36K
Turnover:74.19K
Market Cap:68.25M
PE:-3.79
High:1.11
Open:1.04
Low:1.03
Close:1.07
Loading ...

BRIEF-Cytosorbents Corp - Extends Expiration Date Of Series B Right Warrants To June 10, 2025 - SEC Filing

Reuters
·
04 Apr

Cytosorbents Corp - Extends Expiration Date of Series B Right Warrants to June 10, 2025 - SEC Filing

THOMSON REUTERS
·
04 Apr

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

PR Newswire
·
04 Apr

CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.

Zacks Small Cap Research
·
04 Apr

Cytosorbents Price Target Maintained With a $1.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr

Cytosorbents’ Neutral Rating Amid Revenue Shortfall and Strategic Reorganization

TIPRANKS
·
03 Apr

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
01 Apr

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
01 Apr

BRIEF-Cytosorbents Reports Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights

Reuters
·
01 Apr

BRIEF-Cytosorbents Corp - On March 25, Determined To Restate 2023 Financial Statements Due To Misstatements - SEC Filing

Reuters
·
01 Apr

Cytosorbents Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Cytosorbents Corp - on March 25, Determined to Restate 2023 Financial Statements Due to Misstatements - SEC Filing

THOMSON REUTERS
·
01 Apr

CytoSorbents Q4 2024 Adj. EPS $(0.03) Beats $(0.06) Estimate, Sales $9.200M Miss $10.100M Estimate

Benzinga
·
01 Apr

CytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last year

TIPRANKS
·
01 Apr

Cytosorbents FY Product Gross Margin 71%

THOMSON REUTERS
·
01 Apr

Cytosorbents FY EPS USD -0.38

THOMSON REUTERS
·
01 Apr

Cytosorbents Corp: Expect Modest Decline in Overall Product Sales for Q1 2025

THOMSON REUTERS
·
01 Apr

Cytosorbents Corp expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
22 Mar

Cytosorbents Corp - Reaffirms Preliminary Financial Expectations for Q4 and FY 2024 - SEC Filing

THOMSON REUTERS
·
21 Mar

Cytosorbents Corp: Continues to Expect Regulatory Decisions on Drugsorb!"-Atr Marketing Applications in 2025

THOMSON REUTERS
·
21 Mar